// App-Quantinova.ai

Mo1364 : SAFETY AND EFFICACY OF 3% SODIUM TETRADECYL SULFATE FOAM SCLEROTHERAPY FOR THE TREATMENT OF LIVER CYSTS IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

Researchers

Presenter

  • Ioan-Andrei Iliuta

Principal Investigators

  • Beili Shi

  • Moumita Barua

  • Korosh Khalili

  • York Pei

  • Eran Shlomovitz

Medical Centers

  • Universtiy Health Network, Toronto, ON, Canada

  • Surgical Oncology, University Health Network, Toronto, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Sodium tetradecyl sulfate

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim